Introduction: Chronic gastritis with Helicobacter pylori is a common condition that progresses in 1-3% of cases to gastric adenocarcinoma. The purpose of this work was to identify high-risk patients in the OLGA and OLGIM classifications. Methods: This was a 4-year and 8-month descriptive retrospective study in N’Djamena. Included were all gastric biopsies for histological analysis in the Department of Pathological Anatomy and Cytology. Results: one hundred and fifty-two gastric biopsies were analyzed, including 79 cases of chronic gastritis. The average age of patients was 46.53 years with extremities of 11 and 80 years. Males account for 54.3% compared to 45.7% for females. The sex ratio was 1.2. High-risk cases vary 28.6% according to OLGA and 4.3% according to OLGIM. A statistically significant correlation was found between the OLGA and OLGIM stages and age over 55 (p = 0.0088). OLGIM underestimates 85% of high-risk cases according to OLGA. The level of risk increases with age. Eight cases of dysplasia were identified, including 5 cases (62.5%) associated with high-risk OLGA stages and 1 case (12.5%) with high-risk OLGIM stages. Seven cases of dysplasia (87.5%) were associated with low-risk OLGIM and 3 cases (37.5%) were associated with low-risk OLGA stages. Conclusion: OLGA and OLGIM systems in addition to the Sydney system allow the identification of chronic gastritis with high-risk Helicobacter pylori that evolves towards gastric adenocarcinoma.
| Published in | American Journal of Health Research (Volume 10, Issue 5) |
| DOI | 10.11648/j.ajhr.20221005.12 |
| Page(s) | 193-196 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Chronic Gastritis, H. pylori, OLGA and OLGIM, Chad
| [1] | Paré P, Shaffer EA, Thomson ABR, Menard DB, Boivin M. Principes fondamentaux de gastro-entérologie. 5e ed. Canada: Janssen-ortho; 2005. [Fundamentals of Gastroenterology]. |
| [2] | World Gastroenterology Organisation Global Guidelines. Helicobacter pylori dans les pays en voie de développement. WGO Global Guideline. Août 2010: 1-16. [Helicobacter pylori in developing countries. WGO Global Guideline]. |
| [3] | Bessimbaye N, Moussa AM, Habkreo M, Moukhtar AS, Ouchemi C. Biochemical and resistance profil of Helicobacter pylori isolated in N’Djamena in Chad. Journal of Drug Delivery and Therapeutics. 2021; 11 (5-S): 33-41. |
| [4] | DE Korwin J. D. cancers gastriques et Helicobacter pylori. POST’U. 2003: 1-10. [gastric cancers and Helicobacter pylori.]. |
| [5] | Price AB. The Sydney system: histological division. J Gastroenterol Hepatol. 1991; 6: 209–22. |
| [6] | Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008 Aug; 40 (8): 650–8. |
| [7] | Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010 Jun; 71 (7): 1150-8. |
| [8] | Noah DN, Andoulo FA, Bagnaka SE, Antangana PJA, Tzeuton C, Ndam ECN. Valeur de l’endoscopie de routine dans le diagnostic de la gastrite chronique antrale à Yaoundé. Revue de la Médecine et de pharmacie. 2015; 5 (1): 491-98. [Value of routine endoscopy in diagnosis of chronic antral gastritis in Yaoundé. Journal of Medicine and Pharmacy.]. |
| [9] | Bagny A, Darré T, Bouglouga O, Lawson-Ananissoh LH, Kaaga YL, El-Hadj R, et al. Gastrite chronique à Helicobacter pylori au CHU Campus de Lomé (Togo). J Rech Sci Univ. Lomé (Togo). 2014; 16 (3): 495-502. [Chronic gastritis at Helicobacter pylori at CHU Campus de Lomé (Togo)]. |
| [10] | Doffou SA, Bangoura AD, Kouamé GD, Yaogo A, Kissi H, Allassan KM et al. Corrélation entre l’intensité de l’infection à Helicobacter pylori et la sévérité de l’atrophie gastrique et de la métaplasie intestinale gastrique selon le système Sydney. Rev int méd abj-RISM. 2019; 21 (4): 319-25. [Correlation between the intensity of Helicobacter pylori infection and the severity of gastric atrophy and gastric intestinal metaplasia in the Sydney system]. |
| [11] | Tagzout D, Tebaibia A. Diagnostic histologique de l’infection à Helicobacter pylori: prévalence et aspects histo-pathologiques. La revue de la médecine interne. Déc 2019; 40: A105-A214. [Histological diagnosis of Helicobacter pylori infection: prevalence and histopathological aspects. The review of internal medicine]. |
| [12] | Nakhli A, Bouchabou B, Hemdani N, Romdhan HB, Nejma HB, Ennaifer R. Diagnostic positif et variations anatomopathologiques au cours des gastrites chez les patients sous inhibiteurs de la pompe à protons. La Revue de médecine interne. 2019; 40: A101–A220. [Positive diagnosis and pathological changes during gastritis in patients receiving proton pump inhibitors. The Journal of Internal Medicine]. |
| [13] | Slama SB, Ghachem DB, Dhaoui A, Jomni MT, Dougui MT, Bellil K. Gastrites chroniques à Helicobacter pylori: évaluation des systèmes OLGA et OLGIM. PAMJ. Fév 2016; 23 (28): 1-8. [Chronic gastritis with Helicobacter pylori: OLGA and OLGIM assessment]. |
| [14] | Darré T, Amégbor K, Bagny A, Sewa E, Tchangai B, Sahiye E, et al. Profil Histo-épidemiologique des gastrites chroniques et infection à Helicobacter pylori: A propos de 296 cas de Biopsies au Togo. J Afr Chir Digest. 2013; 13 (1): 1426-30. [Chronic gastritis and Helicobacter pylori infection: About 296 cases of Biopsies in Togo]. |
| [15] | Zeitoum JD, Talis AC, Lefevre J. Hépatologie Gastrologie-Entérologie Chirurgie Viscérale. 6e ed. Paris: Vernazobres-Grego; 2017. [Hepatology Gastrology-Enterology Visceral Surgery]. |
| [16] | Marcos-Pinto R, Carneiro F, Dinis-Ribeiro M, Wen X, Lopes C, Figueiredo C et al. First-degree relatives of patients with earlyonset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Aliment Pharmacol Ther. 2012 Jun; 35 (12): 1451-9. |
| [17] | Martinez D, Otero W, Ricaurte O. A case and control study of the OLGA system’s impact on detection of chronic atrophic gastritis in colombia. Rev col Gastroenterol. 2016; 31 (4): 360-6. |
| [18] | Bulbuloglu E, Dagmura H, Daldal E, Deresoy A, Bakir H, Ozsoy U et al. Can simple tests prior to endoscopy predict the OLGA stage of Gastritis? Healthcar. 2020 july 24; 8 (230): 1-11. |
| [19] | Benoit A, Hoyeau N, Fléjou JF. Diagnostic d’infection à Helicobacter pylori sur biopsies gastriques: coloration standard, coloration spéciale ou immunohistochimie? J Ana pathol. 2018; 03 (009): 1-7. [Diagnostic d’infection à Helicobacter pylori sur biopsies gastriques: coloration standard, coloration spéciale ou immunohistochimie?]. |
| [20] | Zhou Y, Li HY, Zhang JJ, Chen XY, Ge ZZ, Li XB et al. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer. WJG. 2016 Apr 7; 22 (13): 3670-78. |
| [21] | Brkic N, Terzic V, Svageli M, Cvrkovic M. The prevalence and characteristics of Helicobacter pylori-associated gastritis in dyspeptic patient in Eastern Croatia, determined by immunohistochemistry. Period biol. 2017; 119 (1): 75-80. |
| [22] | Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura. N. Comparison of Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients. World J Gastroenterol. 2005; 11 (7): 976-81. |
| [23] | Guglielmi DS, D’angelo F, Bichard P, Lepilliez V, Frossard JL. Métaplasie intestinale gastrique et risque de cancer: quelle surveillance? Rev Med Suisse. 28 Août 2019; 15: 1502-5. [Gastric intestinal metaplasia and cancer risk: what surveilance?]. |
| [24] | Moussata D, deKorwin JD. Gastrites chroniques. EMC-Gastro-entérologie. Janvier 2015; 10 (1): 1-12. [Chronic gastritis. EMC-Gastroenterology. EMC-Gastroenterology]. |
APA Style
Nemian Meurde, Mayanna Habkreo, Ali Mahamat Moussa, Allaboursa Seid Adji, Mahamat Ali Hachim, et al. (2022). Chronic Gastritis at Helicobacter Pylori: Relevance of Classifications OLGA and OLGIM. American Journal of Health Research, 10(5), 193-196. https://doi.org/10.11648/j.ajhr.20221005.12
ACS Style
Nemian Meurde; Mayanna Habkreo; Ali Mahamat Moussa; Allaboursa Seid Adji; Mahamat Ali Hachim, et al. Chronic Gastritis at Helicobacter Pylori: Relevance of Classifications OLGA and OLGIM. Am. J. Health Res. 2022, 10(5), 193-196. doi: 10.11648/j.ajhr.20221005.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajhr.20221005.12,
author = {Nemian Meurde and Mayanna Habkreo and Ali Mahamat Moussa and Allaboursa Seid Adji and Mahamat Ali Hachim and Ndongar Abel and Mbaiguaguem Eric},
title = {Chronic Gastritis at Helicobacter Pylori: Relevance of Classifications OLGA and OLGIM},
journal = {American Journal of Health Research},
volume = {10},
number = {5},
pages = {193-196},
doi = {10.11648/j.ajhr.20221005.12},
url = {https://doi.org/10.11648/j.ajhr.20221005.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajhr.20221005.12},
abstract = {Introduction: Chronic gastritis with Helicobacter pylori is a common condition that progresses in 1-3% of cases to gastric adenocarcinoma. The purpose of this work was to identify high-risk patients in the OLGA and OLGIM classifications. Methods: This was a 4-year and 8-month descriptive retrospective study in N’Djamena. Included were all gastric biopsies for histological analysis in the Department of Pathological Anatomy and Cytology. Results: one hundred and fifty-two gastric biopsies were analyzed, including 79 cases of chronic gastritis. The average age of patients was 46.53 years with extremities of 11 and 80 years. Males account for 54.3% compared to 45.7% for females. The sex ratio was 1.2. High-risk cases vary 28.6% according to OLGA and 4.3% according to OLGIM. A statistically significant correlation was found between the OLGA and OLGIM stages and age over 55 (p = 0.0088). OLGIM underestimates 85% of high-risk cases according to OLGA. The level of risk increases with age. Eight cases of dysplasia were identified, including 5 cases (62.5%) associated with high-risk OLGA stages and 1 case (12.5%) with high-risk OLGIM stages. Seven cases of dysplasia (87.5%) were associated with low-risk OLGIM and 3 cases (37.5%) were associated with low-risk OLGA stages. Conclusion: OLGA and OLGIM systems in addition to the Sydney system allow the identification of chronic gastritis with high-risk Helicobacter pylori that evolves towards gastric adenocarcinoma.},
year = {2022}
}
TY - JOUR T1 - Chronic Gastritis at Helicobacter Pylori: Relevance of Classifications OLGA and OLGIM AU - Nemian Meurde AU - Mayanna Habkreo AU - Ali Mahamat Moussa AU - Allaboursa Seid Adji AU - Mahamat Ali Hachim AU - Ndongar Abel AU - Mbaiguaguem Eric Y1 - 2022/10/18 PY - 2022 N1 - https://doi.org/10.11648/j.ajhr.20221005.12 DO - 10.11648/j.ajhr.20221005.12 T2 - American Journal of Health Research JF - American Journal of Health Research JO - American Journal of Health Research SP - 193 EP - 196 PB - Science Publishing Group SN - 2330-8796 UR - https://doi.org/10.11648/j.ajhr.20221005.12 AB - Introduction: Chronic gastritis with Helicobacter pylori is a common condition that progresses in 1-3% of cases to gastric adenocarcinoma. The purpose of this work was to identify high-risk patients in the OLGA and OLGIM classifications. Methods: This was a 4-year and 8-month descriptive retrospective study in N’Djamena. Included were all gastric biopsies for histological analysis in the Department of Pathological Anatomy and Cytology. Results: one hundred and fifty-two gastric biopsies were analyzed, including 79 cases of chronic gastritis. The average age of patients was 46.53 years with extremities of 11 and 80 years. Males account for 54.3% compared to 45.7% for females. The sex ratio was 1.2. High-risk cases vary 28.6% according to OLGA and 4.3% according to OLGIM. A statistically significant correlation was found between the OLGA and OLGIM stages and age over 55 (p = 0.0088). OLGIM underestimates 85% of high-risk cases according to OLGA. The level of risk increases with age. Eight cases of dysplasia were identified, including 5 cases (62.5%) associated with high-risk OLGA stages and 1 case (12.5%) with high-risk OLGIM stages. Seven cases of dysplasia (87.5%) were associated with low-risk OLGIM and 3 cases (37.5%) were associated with low-risk OLGA stages. Conclusion: OLGA and OLGIM systems in addition to the Sydney system allow the identification of chronic gastritis with high-risk Helicobacter pylori that evolves towards gastric adenocarcinoma. VL - 10 IS - 5 ER -
Email: